Race, common genetic variation, and therapeutic response disparities in heart failure.


Journal Article (Review)

Because of its comparatively recent evolution, Homo sapiens exhibit relatively little within-species genomic diversity. However, because of genome size, a proportionately small amount of variation creates ample opportunities for both rare mutations that may cause disease as well as more common genetic variations that may be important in disease modification or pharmacogenetics. Primarily because of the East African origin of modern humans, individuals of African ancestry (AA) exhibit greater degrees of genetic diversity than more recently established populations, such as those of European ancestry (EA) or Asian ancestry. Those population effects extend to differences in frequency of common gene variants that may be important in heart failure natural history or therapy. For cell-signaling mechanisms important in heart failure, we review and present new data for genetic variation between AA and EA populations. Data indicate that: 1) neurohormonal signaling mechanisms frequently (16 of the 19 investigated polymorphisms) exhibit racial differences in the allele frequencies of variants comprising key constituents; 2) some of these differences in allele frequency may differentially affect the natural history of heart failure in AA compared with EA individuals; and 3) in many cases, these differences likely play a role in observed racial differences in drug or device response.

Full Text

Duke Authors

Cited Authors

  • Taylor, MR; Sun, AY; Davis, G; Fiuzat, M; Liggett, SB; Bristow, MR

Published Date

  • December 2014

Published In

Volume / Issue

  • 2 / 6

Start / End Page

  • 561 - 572

PubMed ID

  • 25443111

Pubmed Central ID

  • 25443111

Electronic International Standard Serial Number (EISSN)

  • 2213-1787

Digital Object Identifier (DOI)

  • 10.1016/j.jchf.2014.06.010


  • eng

Conference Location

  • United States